Cargando…

Efficacy of Nonpreserved Sodium Hyaluronate Artificial Tears in Dry Eye Disease Patients Treated with Prostaglandin Analogs for Primary Open-Angle Glaucoma: A Prospective, Nonrandomized, Open-Label Pilot Study

PURPOSE: Dry eye disease (DED) can be triggered using preserved ophthalmic formulations or prostaglandin analogs. In this prospective, nonrandomized, open-label pilot study, we evaluated the efficacy of a 0.15% hyaluronic acid (HA) nonpreserved ophthalmic formulation in decreasing DED symptoms in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coco, Giulia, Iannetta, Danilo, Febbraro, Igino, Elmo, Ester, Manni, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733995/ https://www.ncbi.nlm.nih.gov/pubmed/36505508 http://dx.doi.org/10.1155/2022/1320996

Ejemplares similares

A Prospective Study Evaluating IOP Changes after Switching from a Therapy with Prostaglandin Eye Drops Containing Preservatives to Nonpreserved Tafluprost in Glaucoma Patients
por: Ranno, Stefano, et al.
Publicado: (2012)

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
por: Topouzis, Fotis, et al.
Publicado: (2019)

Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma
por: Tomić, Martina, et al.
Publicado: (2013)

Cytokine biomarkers in tear film for primary open-angle glaucoma
por: Gupta, Divakar, et al.
Publicado: (2017)

The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes
por: Tsikripis, Panagiotis, et al.
Publicado: (2013)

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
por: Panarelli, Joseph F., et al.
Publicado: (2023)

The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma
por: Meda, Roman, et al.
Publicado: (2017)

Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
por: Park, Ji-Hye, et al.
Publicado: (2021)

Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
por: Horsley, Michael B, et al.
Publicado: (2009)

Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2014)

Prospective, noncomparative, nonrandomized case study of short-term outcomes of 360° suture trabeculotomy ab interno in patients with open-angle glaucoma
por: Sato, Tomoki, et al.
Publicado: (2015)

Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study
por: Batlle, Juan F., et al.
Publicado: (2021)

Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma
por: Siddiqui, Mehdi, et al.
Publicado: (2019)

Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
por: Tang, Wenquan, et al.
Publicado: (2019)

Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
por: Hu, Jason, et al.
Publicado: (2020)

Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
por: Seong, Hyo Jin, et al.
Publicado: (2021)

A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease
por: Friedman, Neil J, et al.
Publicado: (2016)

Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
por: Tamçelik, Nevbahar, et al.
Publicado: (2017)

Prostaglandin analogues in angle closure glaucoma
por: Gupta, Pulkit, et al.
Publicado: (2011)

Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
por: Schwartz, Gail F, et al.
Publicado: (2011)

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Eyawo, Oghenowede, et al.
Publicado: (2009)

Lactones in the Synthesis of Prostaglandins and Prostaglandin Analogs
por: Tănase, Constantin, et al.
Publicado: (2021)

Association Between Open Payments–Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US
por: Nguyen, Andrew M., et al.
Publicado: (2022)

Lasers in primary open angle glaucoma
por: Sihota, Ramanjit
Publicado: (2011)

Medical treatment of open-angle glaucoma
por: Kyari, Fatima, et al.
Publicado: (2012)

Novel therapies for open-angle glaucoma
por: Wentz, Scott M., et al.
Publicado: (2014)

Micropulse Trabeculoplasty in Open Angle Glaucoma
por: Valera-Cornejo, Diego Alejandro, et al.
Publicado: (2018)

Neuroinflammation in Primary Open-Angle Glaucoma
por: Vernazza, Stefania, et al.
Publicado: (2020)

Management of chronic open-angle glaucoma
por: Philippin, Heiko
Publicado: (2021)

Biochemical–molecular–genetic biomarkers in the tear film, aqueous humor, and blood of primary open-angle glaucoma patients
por: Pinazo-Durán, Maria D., et al.
Publicado: (2023)

Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
por: Kocabeyoglu, Sibel, et al.
Publicado: (2015)

Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
por: Vold, Steven D., et al.
Publicado: (2016)

Prostaglandin analogs in ophthalmology
por: Subbulakshmi, S, et al.
Publicado: (2023)

Color visual acuity in preperimetric glaucoma and open-angle glaucoma
por: Ouchi, Junko, et al.
Publicado: (2019)

The Effects of Trabeculectomy on Pseudoexfoliation Glaucoma and Primary Open-Angle Glaucoma
por: Li, Fan, et al.
Publicado: (2020)

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2010)

A Comparison of the Clinical Outcomes between Arthroscopic and Open Rotator Cuff Repair in Patients with Rotator Cuff Tear: A Nonrandomized Clinical Trial
por: Zarezadeh, Abolghasem, et al.
Publicado: (2020)

Erratum to: Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
por: Vold, Steven D., et al.
Publicado: (2016)

Primary open-angle glaucoma: everyone's business
por: Faal, Hannah
Publicado: (2012)

Primary open-angle glaucoma: Reader feedback
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1mqrf4cbfcd973qf0lrc9uf3oh